Yoanna Ivanova Kaneva

Dr. Yoanna Ivanova Kaneva

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2026 in Genes
Verified
Journal Article
Open access
PDF file
NVNevyana Valentinova Veleva
Nevyana Valentinova Veleva
KGKiril Genov
Kiril Genov
KKKunka Kamenarova
Kunka Kamenarova
YKYoanna Ivanova Kaneva
Yoanna Ivanova Kaneva
KMKalina Mihova
Kalina Mihova
AOAlexander Oscar
Alexander Oscar
The term “childhood glaucoma” summarizes a heterogeneous group of diseases characterized by elevated intraocular pressure and associated optic nerve damage. Secondary glaucoma may develop based on non-acquired ocular anomalies, the most common of which are anterior segment dysgeneses. We present a rare case of infantile childhood glaucoma resulting from anterior segment dysgenesis due to a homozygous mutation c.1881delG, p.(Arg627Serfs*6), leading to loss of function in the CPAMD8 gene.

1 June 2026 in Acta Medica Bulgarica
Verified
Journal Article
Open access
GDG. Dimitrov
G. Dimitrov
GDG. Dimitrova
G. Dimitrova
ALA. Levi
A. Levi
NVNevyana Veleva-Krasteva
Nevyana Veleva-Krasteva
OMO. Mladenov
O. Mladenov
AOA. Oscar
A. Oscar
This study presents different treatments, including both medication and glasses, that affect the progression of myopia in children over time. A total of 250 children aged 6 to 16 were evaluated for a period of 36 months. For the purpose of the study, four groups were formed: one group of pediatric patients receiving low-dose atropine (0.01%), another group wearing defocus-modifying glasses, a third group receiving both treatments, and a control group with no treatment. Key biometric indicators, such as axial length, spherical equivalent, and best-corrected visual acuity, were measured at the start of the study and after that every six months. Non-parametric statistical methods were used to compare changes within each group over time and to identify differences between groups. The protocol achieved high data completeness and showed significant changes within the groups (p<0.001). Clear differences between groups appeared after 12 months. The results suggest that combining atropine and defocus lenses is most effective in slowing myopia progression while maintaining good vision.

23 October 2026 in Genes
Verified
Journal Article
Open access
PDF file
YKYoanna Ivanova Kaneva
Yoanna Ivanova Kaneva
KKKunka Kamenarova
Kunka Kamenarova
AOAlexander Oscar
Alexander Oscar
GDGabriel Dimitrov
Gabriel Dimitrov
VHVasil Haykin
Vasil Haykin
NVNevyana Veleva-Krasteva
Nevyana Veleva-Krasteva
Background/Objectives: Syndromic retinitis pigmentosa (SRP) presents a significant diagnostic challenge due to marked clinical and genetic heterogeneity. This study aimed to characterize the molecular spectrum of SRP in the previously understudied Bulgarian population, to define its regional allelic architecture and to relate the genetic findings to the main clinical forms of the disease. Methods: A single-centre, retrospective cohort study included 31 patients from 28 unrelated families diagnosed with SRP at the Department of Ophthalmology, University Hospital “Alexandrovska,” Sofia, Bulgaria. The clinical diagnosis was established by ophthalmological and systemic assessment. Molecular diagnosis was established using whole-exome sequencing of nuclear and mitochondrial DNA and/or targeted inherited retinal disease panel sequencing, complemented by copy number variation analysis. Variants were filtered according to rarity and sequencing quality and classified according to ACMG criteria. Results: The underlying etiology was resolved in all 31 patients across ten ciliary and mitochondrial loci (USH2A, USH1C, ADGRV1, CDH23, IFT54, BBS1, BBS4, BBS10, MKKS, and MT-ATP6). Usher syndrome accounted for 77.41% of cases, followed by Bardet–Biedl syndrome (16.13%), Senior-Løken syndrome spectrum (3.23%), and NARP syndrome (3.23%). Six novel variants were identified. A diagnostic latency of approximately 30 years was observed between the clinical diagnosis and the genetic verification, although the first manifestations, mostly extraocular (congenital hearing loss or polydactyly), appeared in childhood. The allelic landscape demonstrated regional enrichment of the Slavic founder USH2A variant p.(Trp3955*) and the p.(Gly3142*) nonsense variant, while the Western European c.2299delG allele was less prominent. Conclusions: This study defines the molecular spectrum of SRP in a Bulgarian cohort and demonstrates a distinct regional allelic architecture. Recognition of early extraocular manifestations and regional variant frequencies may facilitate earlier diagnosis, improve genetic counseling, and support multidisciplinary management and mutation-specific therapeutic approaches.